Study of BEST1 Vitelliform Macular Dystrophy

Abroad (travel likely)Recruiting

Conditions

Best Vitelliform Macular Dystrophy · Retinitis Pigmentosa

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Columbia University Irving Medical Center, New York, New York, United States
Contact: Study coordinator (Stephen H Tsang, MD, PhD) · sht2@columbia.edu · 212-342-1186
Institut de la Vision/Centre de maladies rares du Centre Hospitalier National Ophtalmologique des Quinze-Vingts, Paris, France
Contact: Study coordinator (Isabelle Audo, MD, PhD) · isabelle.audo@inserm.fr · +33 1 40 02 14 30
Contact: Study coordinator (Camille Andrieu, MD) · candrieu@15-20.fr · +33 1 40 02 14 51
Contact: Principal Investigator (Isabelle Audo, MD, PhD)
Eberhard Karls University Tubingen, Tübingen, Germany
Contact: Study coordinator (Laura Kuehlewein, MD) · laura.kuehlewein@med.uni-tuebingen.de · +49 07071 29-88088
Contact: Study coordinator (Katarina Stingl, MD) · katarina.stingl@med.uni-tuebingen.de · +49 7071 29 87421
Contact: Principal Investigator (Eberhart Zrenner, MD)

Study leads

Stephen H Tsang, MD, PhD
Principal Investigator
Columbia University

View source on ClinicalTrials.gov Contact study team (email)